35-37周妊娠中胎儿偏小或生长受限时的眼动脉多普勒超声
这项前瞻性观察研究纳入2287例妊娠,在35+0至36+6周测量母体眼动脉收缩期峰值流速比值(PSV比值)、平均动脉压和胎盘生长因子。无高血压疾病的胎儿生长受限(FGR)和小于胎龄儿(SGA)组PSV比值和MAP MoM较未受影响组升高,PlGF MoM降低,但变化幅度小于子痫前期和妊娠高血压组;非高血压妊娠中PSV比值与出生体重Z评分呈线性负相关。
要点
- 无高血压疾病的FGR和SGA组眼动脉PSV比值较未受影响组升高,MAP MoM升高,PlGF MoM降低。
- 无高血压疾病的SGA以PSV1降低为主,高血压疾病者以PSV2升高为主。
- 非高血压妊娠中PSV比值和MAP MoM与出生体重Z评分呈线性负相关。
核心结论
- 假设眼动脉PSV比值反映心输出量与外周血管阻力的相互作用,非高血压妊娠中PSV比值与出生体重Z评分的线性关联提示胎儿大小与心血管反应之间存在连续的生理关系,而非小胎儿与非小胎儿之间高外周阻力与低心输出量的二分关系。
研究设计与样本
- 前瞻性观察研究,纳入2287例妊娠,在35+0至36+6周常规医院访视时测量母体眼动脉PSV比值、收缩期第一峰(PSV1)和第二峰(PSV2)、MAP和血清PlGF;PSV比值、MAP和PlGF转换为中位数倍数(MoM)或delta值,比较SGA、FGR、PE和GH组与未受影响组的中位MoM或delta。
关键影像表现/征象
- 与未受影响妊娠相比,FGR组PSV比值delta均值0.042(95%CI 0.007-0.076)、SGA组0.032(95%CI 0.016-0.049)升高。
- 与未受影响妊娠相比,FGR组MAP MoM均值1.028(95%CI 1.006-1.050)、SGA组1.048(95%CI 1.035-1.060)升高。
- 与未受影响妊娠相比,FGR组PlGF MoM均值0.495(95%CI 0.393-0.622)、SGA组0.648(95%CI 0.562-0.747)降低。
- 无高血压疾病的SGA主要特征为PSV1降低,高血压疾病者主要为PSV2升高。
- 非高血压妊娠中PSV比值delta和MAP MoM与出生体重Z评分呈线性负相关,小新生儿值升高、大新生儿值降低;PlGF MoM与出生体重Z评分呈二次关系,小新生儿PlGF低、大新生儿PlGF高。
诊断标准与关键数值
- 与未受影响妊娠相比,FGR组PSV比值delta均值0.042(95%CI 0.007-0.076)、SGA组0.032(95%CI 0.016-0.049)。
- 与未受影响妊娠相比,FGR组MAP MoM均值1.028(95%CI 1.006-1.050)、SGA组1.048(95%CI 1.035-1.060)。
- 与未受影响妊娠相比,FGR组PlGF MoM均值0.495(95%CI 0.393-0.622)、SGA组0.648(95%CI 0.562-0.747)。
- 眼动脉PSV比值delta与log10 MAP MoM相关(0.124(95%CI 0.069-0.178)),与log10 PlGF MoM相关(-0.238(95%CI -0.289至-0.185))。
临床应用与阅片要点
- 在35+0至36+6周超声检查中可测量母体眼动脉PSV比值、PSV1和PSV2,结合MAP和PlGF评估胎儿生长情况。
- 无高血压疾病的SGA以PSV1降低为主,高血压疾病者以PSV2升高为主,阅片时注意区分波形特征。
- 非高血压妊娠中PSV比值和MAP MoM与出生体重Z评分呈线性负相关,小新生儿值升高、大新生儿值降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: First, to compare the ophthalmic artery peak systolic velocity (PSV) ratio at 35-37 weeks' gestation among women who delivered small-for-gestational-age (SGA) or growth-restricted (FGR) neonates in the absence of hypertensive disorders, women who developed pre-eclampsia (PE) or gestational hypertension (GH) and those without SGA, FGR, PE or GH. Second, to examine the association of PSV ratio with placental growth factor (PlGF) and mean arterial pressure (MAP). Third, to assess the associations of PSV ratio, PlGF and MAP with birth-weight Z-score and percentile.
METHODS: This was a prospective observational study in women attending for a routine hospital visit at 35 + 0 to 36 + 6 weeks' gestation. This visit included recording of maternal demographic characteristics and medical history, ultrasound examination of fetal anatomy and growth, and measurement of maternal ophthalmic artery PSV ratio, first (PSV1) and second (PSV2) peaks of systolic velocity, MAP and serum PlGF. The values of PSV ratio, MAP and PlGF were converted to multiples of the median (MoM) or delta values, and the median MoM or delta of these variables in the SGA, FGR, PE and GH groups were compared with those in the unaffected group. Regression analysis was used to examine the relationship of PSV ratio delta, PlGF MoM and MAP MoM with birth-weight Z-score after exclusion of PE and GH cases. Regression analysis was also used to examine the association of PSV ratio delta with log10 PlGF MoM and log10 MAP MoM.
RESULTS: The study population included 2287 pregnancies, of which 1954 (85.4%) were not affected by FGR, SGA, PE or GH, 49 (2.1%) were complicated by FGR in the absence of PE or GH, 160 (7.0%) had SGA in the absence of FGR, PE or GH, 60 (2.6%) had PE and 64 (2.8%) had GH. Compared with unaffected pregnancies, in both the FGR and SGA groups, the means of PSV ratio delta (0.042 (95% CI, 0.007-0.076) and 0.032 (95% CI, 0.016-0.049), respectively) and MAP MoM (1.028 (95% CI, 1.006-1.050) and 1.048 (95% CI, 1.035-1.060), respectively) were increased, while the mean of PlGF MoM was decreased (0.495 (95% CI, 0.393-0.622) and 0.648 (95% CI, 0.562-0.747), respectively). However, the magnitude of these changes was smaller than in the PE and GH groups. Ophthalmic artery waveform analysis revealed that the predominant feature of pregnancies complicated by SGA in the absence of hypertensive disorders was a reduction in PSV1, whereas, in those with hypertensive disorders, there was an increase in PSV2. In non-hypertensive pregnancies, there were linear inverse associations of PSV ratio delta and MAP MoM with birth-weight Z-score, with increased values in small neonates and decreased values in large neonates. There was a quadratic relationship between PlGF MoM and birth-weight Z-score, with low PlGF levels in small neonates and high PlGF levels in large neonates. There was a significant correlation of ophthalmic artery PSV ratio delta with both log10 MAP MoM (0.124 (95% CI, 0.069-0.178)) and log10 PlGF MoM (-0.238 (95% CI, -0.289 to -0.185)).
CONCLUSION: Assuming that the ophthalmic artery PSV ratio is a reflection of the interplay between cardiac output and peripheral vascular resistance, the linear association between PSV ratio and birth-weight Z-score in non-hypertensive pregnancies suggests the presence of a continuous physiological relationship between fetal size and cardiovascular response rather than a dichotomous relationship between high peripheral resistance and low cardiac output in small compared with non-small fetuses. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Abdel Azim, Sarno, Wright, et al. Ophthalmic artery Doppler at 35-37 weeks' gestation in pregnancies with small or growth-restricted fetuses. Ultrasound Obstet Gynecol. 2022. PMID: 35000242. doi:10.1002/uog.24854
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。